Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Heidelberg Ion Beam Therapy Center treats first patient using helium ion therapy with RayStation
10/25/2021
STOCKHOLM, Oct. 25, 2021 /PRNewswire/ -- Heidelberg Ion Beam Therapy Center (HIT) has treated its first patient using helium ion therapy with RayStation®* treatment planning system. The treatment is a world first for helium ion...
STOCKHOLM, Oct. 25, 2021 /PRNewswire/ -- Heidelberg Ion Beam Therapy Center (HIT) has treated its first patient using helium ion therapy with RayStation®* treatment planning system. The treatment is a world first for helium ion...
STOCKHOLM, Oct. 25,...
10/25/2021
IO Learning
News
Varian and the Cincinnati Children's/UC Health Proton Therapy Center Complete Enrollment of FAST-01, First Human Clinical Trial of FLASH Therapy for Cancer
10/25/2021
Trial, designed in collaboration with the FlashForward™Consortium, launched and treated first subject in November 2020 PALO ALTO, Calif., and CINCINNATI, Oct. 25, 2021 /PRNewswire/ -- Varian, a Siemens Healthineers...
Trial, designed in collaboration with the FlashForward™Consortium, launched and treated first subject in November 2020 PALO ALTO, Calif., and CINCINNATI, Oct. 25, 2021 /PRNewswire/ -- Varian, a Siemens Healthineers...
Trial, designed in collaboration...
10/25/2021
IO Learning
News
Obsidio, Inc. Expands Clinical Advisory Board With Two New Members
10/22/2021
COLUMBIA, S.C., Oct. 20, 2021 /PRNewswire/ -- Obsidio, Inc., a medical device company pioneering groundbreaking therapies in endovascular embolization, today announced the expansion of its clinical advisory board with the...
COLUMBIA, S.C., Oct. 20, 2021 /PRNewswire/ -- Obsidio, Inc., a medical device company pioneering groundbreaking therapies in endovascular embolization, today announced the expansion of its clinical advisory board with the...
COLUMBIA, S.C., Oct. 20,...
10/22/2021
IO Learning

Advertisement

News
Sirtex Medical With China Grand Pharmaceutical Introduce SIR-Spheres in China
10/11/2021
Milestone marks first procedure of selective internal radiation therapy (SIRT) using SIR-Spheres in mainland China.
Milestone marks first procedure of selective internal radiation therapy (SIRT) using SIR-Spheres in mainland China.
Milestone marks first procedure...
10/11/2021
IO Learning
News
Radboud university medical center study sets new milestone with 90% diagnostic accuracy of lung nodules suspected of cancer using Philips technology for bronchoscopic procedures
10/06/2021
Hospital achieves world-first level of improvement in the diagnostic accuracy of navigation bronchoscopy using Philips Lung Suite combined with the company’s Image Guided Therapy System – Azurion
Hospital achieves world-first level of improvement in the diagnostic accuracy of navigation bronchoscopy using Philips Lung Suite combined with the company’s Image Guided Therapy System – Azurion
Hospital achieves world-first...
10/06/2021
IO Learning
News
HMP Global’s IO Learning Welcomes Dr Steven Yevich as Editor-in-Chief
09/21/2021
Renowned interventional oncology researcher and professor to spearhead editorial efforts of leading educational news source.
Renowned interventional oncology researcher and professor to spearhead editorial efforts of leading educational news source.
Renowned interventional oncology...
09/21/2021
IO Learning

Advertisement

News
Late-Breaking Data Demonstrate Improved Progression-Free Survival in Patients with Metastatic Colorectal Cancer After Treatment with Boston Scientific TheraSphere™ Y-90 Glass Microspheres
09/20/2021
Late-Breaking Data Demonstrate Improved Progression-Free Survival in Patients with Metastatic Colorectal Cancer After Treatment with Boston Scientific TheraSphere™ Y-90 Glass Microspheres
Late-Breaking Data Demonstrate Improved Progression-Free Survival in Patients with Metastatic Colorectal Cancer After Treatment with Boston Scientific TheraSphere™ Y-90 Glass Microspheres
Late-Breaking Data Demonstrate...
09/20/2021
IO Learning
News
IceCure Medical Announces First Peer Reviewed Publication for the 3-Year Interim Analysis of the ICE3 Trial on Cryoablation of Low-Risk, Early-Stage Breast Cancer
09/13/2021
Dr. Richard Fine to present findings at the Mayo Clinc Conference "Breast Cancer Care: Innovation, Disruptive Technologies and Early Adopters 2021"
Dr. Richard Fine to present findings at the Mayo Clinc Conference "Breast Cancer Care: Innovation, Disruptive Technologies and Early Adopters 2021"
Dr. Richard Fine to present...
09/13/2021
IO Learning
News
Study Shows Image-Guided Superficial Radiotherapy Is 99.3 Percent Effective in Treating Common Skin Cancers Without Surgery
09/08/2021
BURR RIDGE, Ill., Sept. 8, 2021 /PRNewswire/ -- SkinCure Oncology, the world leader in providing a comprehensive model for the delivery of Image-Guided Superficial Radiotherapy...
BURR RIDGE, Ill., Sept. 8, 2021 /PRNewswire/ -- SkinCure Oncology, the world leader in providing a comprehensive model for the delivery of Image-Guided Superficial Radiotherapy...
...
09/08/2021
IO Learning

Advertisement

News
The Netherlands Cancer Institute opens doors of new unique hybrid OR in the Netherlands
09/02/2021
Minimally invasive procedure with mobile CT scanner increases precision in cancer treatment.
Minimally invasive procedure with mobile CT scanner increases precision in cancer treatment.
Minimally invasive procedure...
09/02/2021
IO Learning

Subscribe

IO Learning Newsletter

News

News
Novel Endovascular Robotic Surgical System Reaches Midpoint of Pivotal Clinical Trial
09/20/2024
The ACCESS-PVI trial of LIBERTY® Endovascular Robotic Surgical System has enrolled and completed follow-up for 50% of patients.
The ACCESS-PVI trial of LIBERTY® Endovascular Robotic Surgical System has enrolled and completed follow-up for 50% of patients.
The ACCESS-PVI trial of LIBERTY®...
09/20/2024
IO Learning
News
Histotripsy Demonstrates Technical Success, Safety for Primary and Metastatic Liver Tumors
09/04/2024
According to results from the parallel #HOPE4LIVER trials, the novel ablation technique of histotripsy met coprimary end points for technical success and safety among patients with primary and metastatic liver tumors.
According to results from the parallel #HOPE4LIVER trials, the novel ablation technique of histotripsy met coprimary end points for technical success and safety among patients with primary and metastatic liver tumors.
According to results from the...
09/04/2024
IO Learning
News
Sorafenib Plus Transarterial Chemoembolization Improves Survival Outcomes, Response Among Patients With Recurrent Hepatocellular Carcinoma
07/29/2024
According to a phase 3 trial, the addition of sorafenib to TACE improved survival outcomes and response among patients with recurrent intermediate-stage hepatocellular carcinoma after R0 initial hepatectomy and microvascular invasion.
According to a phase 3 trial, the addition of sorafenib to TACE improved survival outcomes and response among patients with recurrent intermediate-stage hepatocellular carcinoma after R0 initial hepatectomy and microvascular invasion.
According to a phase 3 trial,...
07/29/2024
Oncology
News
Thermal Ablation Over Surgical Resection for Patients With Smaller Colorectal Liver Metastases
07/18/2024
According to the phase 3 COLLISION trial, thermal ablation for smaller colorectal liver metastases reduced morbidity and mortality without compromising survival outcomes compared to surgical resection.
According to the phase 3 COLLISION trial, thermal ablation for smaller colorectal liver metastases reduced morbidity and mortality without compromising survival outcomes compared to surgical resection.
According to the phase 3...
07/18/2024
IO Learning
News
Manageable Safety Across Treatment Periods for Durvalumab, Bevacizumab, and TACE Regimen Among Patients With Unresectable Hepatocellular Carcinoma
07/17/2024
According to a post-hoc, exploratory analysis of safety by treatment period in the EMERALD-1 study, durvalumab plus bevacizumab plus transarterial chemoembolization had a manageable safety profile across both treatment periods among patients...
According to a post-hoc, exploratory analysis of safety by treatment period in the EMERALD-1 study, durvalumab plus bevacizumab plus transarterial chemoembolization had a manageable safety profile across both treatment periods among patients...
According to a post-hoc,...
07/17/2024
IO Learning
News
Transit Scientific Announces First Worldwide Case Performed with Innovative Embolic-Delivery Microcatheter
07/09/2024
Transit Scientific Press Release Park City, Utah USA, July 9, 2024 – Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, proudly announces the successful debut of XO...
Transit Scientific Press Release Park City, Utah USA, July 9, 2024 – Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, proudly announces the successful debut of XO...
Transit Scientific Press...
07/09/2024
Vascular Disease Management
Imaging Systems
University Hospitals Cleveland, Siemens Healthineers in New Alliance to Improve Oncology, Cardiovascular and Neurovascular Care for Patients
05/08/2024

Siemens Healthineers and University Hospitals Cleveland News

Siemens Healthineers and University H...
The new alliance will enhance cardiovascular services of the UH Harrington Heart & Vascular Institute with the world’s first clinically available photon-counting CT scanner and the new dual-source CT scanner.
The new alliance will enhance cardiovascular services of the UH Harrington Heart & Vascular Institute with the world’s first clinically available photon-counting CT scanner and the new dual-source CT scanner.
The new alliance will enhance...
05/08/2024
Cath Lab Digest
News
Histotripsy Treatment for Primary and Metastatic Liver Tumors
04/25/2024
At the 2023 CIRSE Annual Meeting, first results from the #HOPE4LIVER trial evaluating histotripsy for primary and metastatic liver tumors were reported.
At the 2023 CIRSE Annual Meeting, first results from the #HOPE4LIVER trial evaluating histotripsy for primary and metastatic liver tumors were reported.
At the 2023 CIRSE Annual...
04/25/2024
IO Learning
News
First-of-Its-Kind Surgical Foam Technology Improves Operating Room Workflow
04/24/2024

Syntervention Press Release

Syntervention Press Release
Rocky Mount, North Carolina, USA, April 24, 2024 — Syntervention, Inc., a medical device company focused on meeting critical needs in the healthcare space, announces the impact of using its SWICKER® Radiopaque Surgical Foam Sponge in open...
Rocky Mount, North Carolina, USA, April 24, 2024 — Syntervention, Inc., a medical device company focused on meeting critical needs in the healthcare space, announces the impact of using its SWICKER® Radiopaque Surgical Foam Sponge in open...
Rocky Mount, North Carolina,...
04/24/2024
EP Lab Digest
News
Fluidx Medical Reveals New Embolic Platform for Internal Bleeding, Tumor Treatment, and Other Uses
11/30/2023
Salt Lake City (UT) – Fluidx Medical today released information about their new ULTRA™ embolic platform designed to make therapeutic embolization procedures safer, better, and faster.   Embolization is a minimally invasive...
Salt Lake City (UT) – Fluidx Medical today released information about their new ULTRA™ embolic platform designed to make therapeutic embolization procedures safer, better, and faster.   Embolization is a minimally invasive...
Salt Lake City (UT) – Fluidx...
11/30/2023
Vascular Disease Management

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use